ECOLAB INC.

ECL 10-K · FY 2025

ECL FY 2025 request

Playground key active
Request URL /api/financials?ticker=ECL&year=2025&quarter=4&full_year_mode=true
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric FY 2025 FY 2024 YoY
Revenue 16,081.2 15,741.4 +2.2%
Show Product Lines breakouts
Product and equipment sales 12,618.5 12,473.6 +1.2%
Product and equipment sales · Global Institutional and Specialty 4,950.4 5,000 -1.0%
Product and equipment sales · Global Life Sciences 709.4 664 +6.8%
Product and equipment sales · Global Water 6,958.7 6,809.6 +2.2%
Service and lease sales 3,462.7 3,267.8 +6.0%
Service and lease sales · Global Institutional and Specialty 1,154.2 1,103.4 +4.6%
Service and lease sales · Global Life Sciences 38.5 35.3 +9.1%
Service and lease sales · Global Pest Elimination 1,246.3 1,162.8 +7.2%
Service and lease sales · Global Water 1,023.7 966.3 +5.9%
Show Business Segments breakouts
Global Institutional and Specialty 6,104.6 6,103.4 0.0%
Global Institutional and Specialty · Asia Pacific 329.2 322.4 +2.1%
Global Institutional and Specialty · CA 250.3 254.1 -1.5%
Global Institutional and Specialty · CN 198.1 182.7 +8.4%
Global Institutional and Specialty · Europe 1,026.1 1,037.5 -1.1%
Global Institutional and Specialty · India, Middle East and Africa 99.1 105.1 -5.7%
Global Institutional and Specialty · Latin America 205.8 209.6 -1.8%
Global Institutional and Specialty · Operating Segments 5,962 5,979.4 -0.3%
Global Institutional and Specialty · US 3,996 3,992 +0.1%
Global Life Sciences 747.9 699.3 +6.9%
Global Life Sciences · Asia Pacific 54.5 37.2 +46.5%
Global Life Sciences · CA 4 2.8 +42.9%
Global Life Sciences · CN 52.6 54.1 -2.8%
Global Life Sciences · Europe 382.4 374.4 +2.1%
Global Life Sciences · India, Middle East and Africa 31 22.4 +38.4%
Global Life Sciences · Latin America 18.3 21.1 -13.3%
Global Life Sciences · Operating Segments 706.1 670.5 +5.3%
Global Life Sciences · US 205.1 187.3 +9.5%
Global Pest Elimination 1,246.3 1,162.8 +7.2%
Global Pest Elimination · Asia Pacific 35.1 32.1 +9.3%
Global Pest Elimination · CA 12.8 11.8 +8.5%
Global Pest Elimination · CN 61.3 60 +2.2%
Global Pest Elimination · Europe 205.7 187.5 +9.7%
Global Pest Elimination · India, Middle East and Africa 7 7.1 -1.4%
Global Pest Elimination · Latin America 60.4 58.7 +2.9%
Global Pest Elimination · Operating Segments 1,219.2 1,140.1 +6.9%
Global Pest Elimination · US 864 805.6 +7.2%
Global Water 7,982.4 7,775.9 +2.7%
Global Water · Asia Pacific 945.7 947.6 -0.2%
Global Water · CA 232.3 224 +3.7%
Global Water · CN 410.4 400.4 +2.5%
Global Water · Europe 1,661.1 1,593.7 +4.2%
Global Water · India, Middle East and Africa 501.1 493 +1.6%
Global Water · Latin America 816.7 810.5 +0.8%
Global Water · Operating Segments 7,679.9 7,483.4 +2.6%
Global Water · US 3,415.1 3,306.7 +3.3%
Show Consolidation Items breakouts
Material Reconciling Items 514 468 +9.8%
Operating Segments 15,567.2 15,273.4 +1.9%
Cost of Revenue 8,930.8 8,899.7 +0.3%
Show Product Lines breakouts
Product and equipment sales 6,955.8 6,990 -0.5%
Service and lease sales 1,975 1,909.7 +3.4%
Show Business Segments breakouts
Corporate · Operating Segments 7.7 5.2 +48.1%
Global Institutional and Specialty · Operating Segments 2,977.7 3,131 -4.9%
Global Life Sciences · Operating Segments 382.6 382.6 0.0%
Global Pest Elimination · Operating Segments 686.3 639.8 +7.3%
Global Water · Operating Segments 4,585.9 4,470.9 +2.6%
Show Equity Components breakouts
Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges · Reclassification Out Of Accumulated Other Comprehensive Income 4.4 4 +10.0%
Show Consolidation Items breakouts
Operating Segments 8,640.2 8,629.5 +0.1%
Selling, General & Administrative 4,257.9 4,228.2 +0.7%
Show Business Segments breakouts
Corporate · Operating Segments 195.2 195.6 -0.2%
Global Institutional and Specialty · Operating Segments 1,626.5 1,646.2 -1.2%
Global Life Sciences · Operating Segments 202.8 196.1 +3.4%
Global Pest Elimination · Operating Segments 295.8 290.6 +1.8%
Global Water · Operating Segments 1,830.1 1,805.3 +1.4%
Show Equity Components breakouts
Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges · Reclassification Out Of Accumulated Other Comprehensive Income 0.5 5.8 -91.4%
Show Consolidation Items breakouts
Operating Segments 4,150.4 4,133.8 +0.4%
Other Nonrecurring Income Expense 154.9 -188.9 +182.0%
Show Product Lines breakouts
Product and equipment, and service and lease · Cost Of Sales 7.7 5.3 +45.3%
Show Business Segments breakouts
Corporate · Operating Segments 150.3 -188.7 +179.7%
Show Consolidation Items breakouts
Operating Segments 150.3 -188.7 +179.7%
Show Income Statement Location breakouts
Cost Of Sales 7.7 5.3 +45.3%
Special (gains) and charges 154.9 -188.9 +182.0%
Operating Income 2,737.6 2,802.4 -2.3%
Show Business Segments breakouts
Corporate · Operating Segments -353.2 -12.1 -2819.0%
Global Institutional and Specialty · Operating Segments 1,357.8 1,202.2 +12.9%
Global Life Sciences · Operating Segments 120.7 91.8 +31.5%
Global Pest Elimination · Operating Segments 237.1 209.7 +13.1%
Global Water · Operating Segments 1,263.9 1,207.2 +4.7%
Show Consolidation Items breakouts
Material Reconciling Items 111.3 103.6 +7.4%
Operating Segments 2,626.3 2,698.8 -2.7%
Non-Operating Income (Expense) -51.4 -51.3 -0.2%
Interest Expense Net 241.1 282.5 -14.7%
Show Equity Components breakouts
Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges · Reclassification Out Of Accumulated Other Comprehensive Income -1.5 -1.9 +21.1%
Income Before Taxes 2,547.9 2,571.2 -0.9%
Income Tax Expense (Benefit) 454.6 439.3 +3.5%
Net Income 2,093.3 2,131.9 -1.8%
Show Equity Components breakouts
Noncontrolling Interest 17.7 19.5 -9.2%
Parent 2,075.6 2,112.4 -1.7%
Retained Earnings 2,075.6 2,112.4 -1.7%
Net Income Loss Attributable To Noncontrolling Interest 17.7 19.5 -9.2%
Net Income 2,075.6 2,112.4 -1.7%
EPS (Basic) 7.33 7.43 -1.3%
EPS (Diluted) 7.28 7.37 -1.2%
Wtd Avg Shares (Basic) 283.3 284.3 -0.4%
Wtd Avg Shares (Diluted) 285.2 286.6 -0.5%
Research & Development 202 207 -2.4%
Interest Income -65.1 -57.8 -12.6%
Comprehensive Income 2,183.3 1,980.8 +10.2%
Professional Fees (FY)
Show Disposal Group Classification breakouts
Disposal Group Disposed Of By Sale Not Discontinued Operations · Global surgical solutions business 3 15.6 -80.8%
Disposal Group Heldforsale Not Discontinued Operations · Global surgical solutions business 3
Show Income Statement Location breakouts
Special (gains) and charges · One Ecolab Initiative Program 30.9 23.7 +30.4%
Interest Expense 306.2 340.3 -10.0%
Operating Lease Lease Income 562.1 534.9 +5.1%

Balance Sheet

Balance Sheet
Metric FY 2025 FY 2024 YoY
Current Assets
Cash & Cash Equivalents 646.2 1,256.8 -48.6%
Accounts Receivable 3,249.4 2,865 +13.4%
Inventory 1,490.4 1,464.9 +1.7%
Other Assets Current 569.6 439 +29.7%
Total Current Assets 5,955.6 6,025.7 -1.2%
Non-Current Assets
Property, Plant & Equipment 4,276.6 3,752.4 +14.0%
Goodwill 9,227 7,907.3 +16.7%
Show Business Segments breakouts
Global Institutional and Specialty 1,041.5 1,024.3 +1.7%
Global Life Sciences 2,490.4 2,408.7 +3.4%
Global Pest Elimination 189.6 169.4 +11.9%
Global Water 5,505.5 4,304.9 +27.9%
Show Business Acquisition breakouts
Series Of Individually Immaterial Business Acquisitions 17.4 156.7 -88.9%
Operating Lease Right-of-Use Assets 765.9 723.2 +5.9%
Other Non-Current Assets 782.7 670.4 +16.8%
Total Assets 24,696.3 22,387.8 +10.3%
Intangible Assets 2,458.5 2,078.8 +18.3%
Deferred Tax Assets 181 155.5 +16.4%
Other Assets
Intangible Assets Net Excluding Goodwill 3,688.5 3,308.8 +11.5%
Current Liabilities
Debt Current 870.4 615.7 +41.4%
Accounts Payable 2,071 1,810 +14.4%
Employee Related Liabilities Current 721.5 727.4 -0.8%
Accrued Income Taxes Current 134.3 127 +5.7%
Other Liabilities Current 1,737.5 1,512.7 +14.9%
Total Current Liabilities 5,534.7 4,792.8 +15.5%
Commercial Paper (Q)
Show Debt Instrument breakouts
U.S. commercial paper program 100
Non-Current Liabilities
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent 546.1 634.9 -14.0%
Show Retirement Plan Type breakouts
Defined Benefit Postretirement Health Coverage · US 90.7 91.5 -0.9%
Pension Plans Defined Benefit · Foreign Plan 383.7 370.5 +3.6%
Pension Plans Defined Benefit · US 66.9 142.8 -53.2%
Deferred Tax Liabilities 329.9 280 +17.8%
Other Non-Current Liabilities 518.7 366.2 +41.6%
Total Liabilities 14,891.8 13,598.6 +9.5%
Other Liabilities
Long Term Debt And Capital Lease Obligations 7,365.9 6,949.2 +6.0%
Operating Lease Liability Noncurrent Excluded From Long Term Debt 596.5 575.5 +3.6%
Stockholders' Equity
Common Stock 369.4 367.8 +0.4%
Additional Paid In Capital Common Stock 7,521.3 7,159.6 +5.1%
Retained Earnings 12,834 11,517.1 +11.4%
Accumulated Other Comprehensive Income -1,874.3 -1,982 +5.4%
Treasury Stock Value -9,079.6 -8,305.2 -9.3%
Total Stockholders' Equity 9,770.8 8,757.3 +11.6%
Minority Interest 33.7 31.9 +5.6%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 9,804.5 8,789.2 +11.6%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -1,874.3 -1,982 +5.4%
Additional Paid In Capital 7,521.3 7,159.6 +5.1%
Common Stock 369.4 367.8 +0.4%
Noncontrolling Interest 33.7 31.9 +5.6%
Parent 9,770.8 8,757.3 +11.6%
Retained Earnings 12,834 11,517.1 +11.4%
Treasury Stock Common -9,079.6 -8,305.2 -9.3%
Total Liabilities & Equity 24,696.3 22,387.8 +10.3%

Cash Flow Statement

Cash Flow Statement
Metric FY 2025 FY 2024 YoY
Operating Activities
Depreciation 672.6 634.9 +5.9%
Adjustment For Amortization 303.8 300.5 +1.1%
Deferred Income Taxes And Tax Credits -33.4 -190.5 +82.5%
Stock-Based Compensation 136.6 134.8 +1.3%
Pension And Other Postretirement Benefit Contributions -77.8 -54.4 -43.0%
Pension And Other Postretirement Benefit Expense 15 14.3 +4.9%
Restructuring Costs 18.8 23.7 -20.7%
Gain Loss On Sale Of Business 1.1 -381.7 +100.3%
Other Non-Cash Items 28.8 24.3 +18.5%
Change in Accounts Receivable -185.9 -146.7 -26.7%
Change in Inventory 36.4 -115.6 +131.5%
Increase Decrease In Other Operating Assets 83.6 -24.3 +444.0%
Change in Accounts Payable 67.7 300 -77.4%
Increase Decrease In Other Operating Liabilities -208 162.7 -227.8%
Net Cash from Operations 2,952.6 2,813.9 +4.9%
Deferred Income Taxes -36.2 -184.6 +80.4%
Investing Activities
Capital Expenditures -1,048.3 -994.5 -5.4%
Proceeds From Sale Of Productive Assets 52.3 11.3 +362.8%
Payments To Acquire Businesses And Interest In Affiliates -1,621.3 -312.9 -418.2%
Proceeds From Divestiture Of Businesses Net Of Cash Divested -14.9 889.7 -101.7%
Other Investing Activities -75 -27.4 -173.7%
Net Cash from Investing -2,707.2 -433.8 -524.1%
Financing Activities
Proceeds From Repayments Of Short Term Debt 98.2 1.9 +5068.4%
Proceeds From Issuance Of Long Term Debt 1,045.6
Repayments Of Long Term Debt -674.2 -630.4 -6.9%
Share Repurchases -783.8 -986.5 +20.5%
Payments Of Dividends Common Stock -753.6 -664.3 -13.4%
Proceeds From Stock Options Exercised 228.2 259.4 -12.0%
Proceeds From Payments For Other Financing Activities -13.7 -3.6 -280.6%
Net Cash from Financing -853.3 -2,024.1 +57.8%
Supplemental
Income Taxes Paid 548.1 647.4 -15.3%
Interest Paid 302.6 342.6 -11.7%
Income Taxes Paid 548.1 647.4 -15.3%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -2.7 -18.7 +85.6%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations -610.6 337.3 -281.0%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 646.2 1,256.8 -48.6%

Values in millions USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key